Cell Therapy for Parkinson’s Disease
Cell therapy for Parkinson’s disease (PD) began in 1979 with the transplantation of fetal rat dopamine-containing neurons that improved motor abnormalities in the PD rat model with good survival of grafts and axonal outgrowth. Thirty years have passed since the 2 clinical trials using cell transplan...
Main Authors: | Takao Yasuhara, Masahiro Kameda, Tatsuya Sasaki, Naoki Tajiri, Isao Date |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2017-09-01
|
Series: | Cell Transplantation |
Online Access: | https://doi.org/10.1177/0963689717735411 |
Similar Items
-
Intracerebral Transplantation of Genetically Engineered Cells for Parkinson's Disease: Toward Clinical Application
by: Takao Yasuhara M.D., Ph.D., et al.
Published: (2007-02-01) -
Regenerative medicine for central nervous system disorders: Role of therapeutic molecules in stem cell therapy
by: Paola Suárez-Meade, et al.
Published: (2015-01-01) -
Spinal cord stimulation exerts neuroprotective effects against experimental Parkinson's disease.
by: Aiko Shinko, et al.
Published: (2014-01-01) -
Encapsulation of Mesenchymal Stem Cells: Dissecting the Underlying Mechanism of Mesenchymal Stem Cell Transplantation Therapy
by: Kyohei Kin, et al.
Published: (2020-10-01) -
Long-Term Continuous Cervical Spinal Cord Stimulation Exerts Neuroprotective Effects in Experimental Parkinson’s Disease
by: Ken Kuwahara, et al.
Published: (2020-06-01)